Results 211 to 220 of about 1,369,975 (301)

Digital heart failure management: Insights from the COPILOT study. [PDF]

Heart Fail Rev
Rolland JM, Øvrebotten T, Damman K, Greene SJ, Myhre PL.   +4 more
europepmc   +1 more source

Use of antiemetics in early pregnancy 2012–2022: A cross‐sectional study

British Journal of Clinical Pharmacology, EarlyView.
Aim Nausea and vomiting in pregnancy impact quality of life, yet many pregnant women feel dismissed by healthcare professionals, despite the safety of first‐line antiemetic treatments for both mother and fetus. Therefore, this study aims to describe the prevalence of patient‐reported antiemetic use in early pregnancy in Copenhagen, Denmark, the changes
Katrine Bak Wraae, Nanna Roed Ballegaard, Mie Lærkeholm Hede, Line Buchgreitz, Ane Lilleøre Rom, Hanne Kristine Hegaard, Nina Olsén Nathan   +6 more
wiley   +1 more source

Geospatial optimization of Air-Mobile Stroke Unit deployment in Norway: expanding the frontiers of neurocritical care. [PDF]

Front Neurol
Jagtenberg CJ, Boer AM, Rehn M, Roislien J, Hov MR, Larsen K.   +5 more
europepmc   +1 more source

Trends in age‐sex‐specific prevalence and incidence of antidepressant dispensation in the Nordic countries: a systematic review

British Journal of Clinical Pharmacology, EarlyView.
Differences in antidepressant dispensation across the Nordic countries have been reported, but existing reviews are based on older data. We conducted a systematic review of population‐based studies reporting prevalence and/or incidence of antidepressant dispensation in the Nordic countries.
Marcel Ballin, Paulina Tuvendal, Carola Bardage, Mats Persson, Mats Talbäck, Rickard Ljung   +5 more
wiley   +1 more source

Automatic monitoring of single-wall MAPSE by transesophageal echocardiography for tracking global left ventricular function irrespective of regional hypokinesia: a secondary analysis. [PDF]

Intensive Care Med Exp
Yu J, Grude O, Berg EAR, Taskén AA, Tannvik TD, Slagsvold KH, Kirkeby-Garstad I, Grenne B, Aakhus S, Kiss G.   +9 more
europepmc   +1 more source

Paternal use of metformin and risk of major congenital malformations: A meta‐analysis of 4 studies

British Journal of Clinical Pharmacology, EarlyView.
Abstract Metformin is the first‐line drug for the treatment of Type 2 diabetes. In 2022, a Danish registry‐based study reported a 40% increased risk of major congenital malformations following paternal exposure during spermatogenesis. This raised widespread concern about the use of metformin in males of reproductive age.
Per Damkier, Marleen M. H. J. van Gelder, Krista F. Huybrechts, Lin‐Chieh Meng, Sonia Hernandez‐Diaz, Jan Nielsen, Bente M. Nørgård, Hedvig Nordeng   +7 more
wiley   +1 more source

Self-reported late effects and chronic fatigue, information needs and follow-up in long-term survivors of Hodgkin lymphoma-a cross-sectional study. [PDF]

Support Care Cancer
Willumsen LH, Smeland KB, Eikeland S, Fosså A, Bersvendsen HS, Fagerli UM, Falk RS, Lie HC, Skaali T, Kiserud CE.   +9 more
europepmc   +1 more source

A scoping review of quality prescribing indicators, rules and criteria for primary care

British Journal of Clinical Pharmacology, EarlyView.
Medication‐related problems (MRPs) place a substantial burden on the healthcare system, contributing to hospital admissions and significant healthcare costs. Quality prescribing indicators (QPIs), rules and criteria serve to educate prescribers about high risk MRPs and to monitor prescribing behaviours. This study aims to summarize existing indicators,
James Nind, Anna Mackintosh, Emma Maddock, Alana Delaforce, Gregory Peterson, Elizabeth Manias, Johnson George   +6 more
wiley   +1 more source

Individually tailored monitoring at home after hospitalization for HEART failure (IT-HEART): design and baseline characteristics of a randomized clinical trial. [PDF]

Heart Fail Rev
Braanaas KS, Dammen T, Fagerland MW, Husebye E, Leinaas A, Schirmer H, Sverre E, Aune E, Myhre PL, Munkhaugen J.   +9 more
europepmc   +1 more source

Alcohol consumption and colorectal carcinogenesis: an exploration of the gut microbial pathway as a potential mediator. [PDF]

Eur J Nutr
Kværner AS, Birkeland E, Avershina E, Botteri E, Bucher-Johannessen C, Knudsen MD, Hjartåker A, Page CM, Hov JR, Song M, Randel KR, Hoff G, Rounge TB, Berstad P.   +13 more
europepmc   +1 more source